OVERVIEW OF BTA EXAMINATION RESULTS IN PULMONARY TB PATIENTS UNDERGOING TREATMENT FOR 2 MONTHS AT HAJI REGIONAL HOSPITAL, EAST JAWA PROVINCE

Abstract

Background: Pulmonary tuberculosis remains a global health problem, including in Indonesia, which ranks second in terms of the highest number of cases. One of the laboratory tests for pulmonary TB is the BTA test. The BTA test is crucial for assessing the success of TB treatment. The initial stage of pulmonary TB treatment is the first 2 months after diagnosis.  Object: The purpose of this study was to determine the results of the BTA test in patients undergoing 2 months of treatment at the RSUD Haji in East Java. Method This study was descriptive, with the population consisting of pulmonary TB patients undergoing 2 months of treatment in the RSUD Haji in East Java. Samples were taken purposively from medical records from January to June 2024, totaling 63 samples. Result: The results showed that of the 63 pulmonary TB samples undergoing treatment for 2 months, 92.06% (58 samples) showed negative BTA results and 7.94% (5 samples) showed positive BTA results. Based on the results of the study, most pulmonary TB patients showed negative BTA results after 2 months of treatment. This occurred because the Anti-Tuberculosis Drugs (ATD) administered during the intensive phase of treatment were able to significantly reduce the number of bacilli, supported by a good immune response and patient compliance in undergoing treatment. Conclusion: .94% of patients still showed positive BTA results, so other factors affecting treatment success, such as compliance, nutrition, and comorbidities, need to be reviewed.